http://www.fpnotebook.com/
Nevirapine
Aka: Nevirapine, Viramune, NVP
- See Also
- Anti-Retroviral Therapy
- Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
- Class
- Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
- Efficacy
- Good benefit in combination with 2 nucleosides
- Dosing
- Start: 200 mg PO qd for 14 days
- If no rash, increase dose to 200 mg PO bid
- Adverse effects
- See NNRTI for class related adverse effects
- Severe hepatoxicity and liver failure risk if pre-treatment CD4 >250 in men or >400 in women
- References
- (2009) Treat Guidel Med Lett 7(78): 11-22